Novel nomograms for castration-resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer.

Jinge ZhaoGuangxi SunBanghua LiaoXingming ZhangCameron M ArmstrongXiaoxue YinJiandong LiuJunru ChenYaojing YangPeng ZhaoQidun TangZhenghao WangZhibin ChenXiong LiQiang WeiXiang LiNi ChenAllen C GaoPengfei ShenHao Zeng

Published in: BJU international (2018)

We developed two novel nomograms to predict the incidence of CRPC and OS for patients with de novo metastatic PCa. These tools may assist in physician decision-making and the designing of clinical trials.

Keyphrases

prostate cancer
clinical trial
decision making
squamous cell carcinoma
small cell lung cancer
radical prostatectomy
primary care
emergency department
risk factors
randomized controlled trial
free survival
soft tissue
bone regeneration
open label
phase iii